Abstract
The introduction of national strategies aimed at improving the well-being of the population of the country is one of the current approaches to reforming the public policies of the countries of the world. It is the socioeconomic determinants of health that determine the conditions in which people are born, grow, live and getting old, as well as the spheres of influence on these conditions, such as public policy, state of economic development, demographic trends, etc.
 The aim. In this way, our research has focused on a comparative analysis of macroeconomic indicators that determine the effectiveness of socioeconomic determinants of healthсare in Europe and Ukraine, that are used to provide scientific justification for the construction of humanistic models for the provision of pharmaceutical care to the population in the context of the rapid stratification of Ukrainian society according to socioeconomic indicators.
 Materials and methods. The research methodology is based on the principles of systems analysis and an interdisciplinary scientific and systemic approach. The study used the empirical method, the method of comparative analysis and synthesis of statistical data, the graphical method.
 Results. A comparative analysis of the socioeconomic determinants of health in the countries of the European region and in Ukraine was carried out on three levels of indicators: the level of health-care expenditure, the structure of health-care expenditure and expenditure on medicines.
 The analysis revealed that in 2019, the average health expenditure of the countries analyzed was 8.2 % of GDP. Only two of the 34 countries - Ukraine and Turkey - have a rate below the 5 % that recommended by WHO.
 Public health financing schemes and compulsory health insurance are the main funding mechanisms in all countries, with the exception of Cyprus. Ukraine, Russia, Greece, Latvia and Bulgaria have the largest share of direct costs to patients as a source of health care financing.
 The results of the analysis of the medicine expenditure indicator as a proportion of total health expenditure showed that the highest level was in Bulgaria (35.4 %), the lowest in Denmark (6.4 %). Overall, five countries have high levels of pharmaceutical expenditures.
 In most European countries, the cost of purchasing medicines has been found to range from 346 to 619 USD per person per year. The highest value of this indicator from the European region is in Switzerland (894 USD per person), and the lowest is in Ukraine (73 USD).
 Based on the results of the comparative analysis, the countries were grouped according to key indicators into three categories - high, medium and low.
 Conclusions. A comparative analysis of key indicators of the socio-economic determinants of health in the country of the European region has been carried out
Highlights
The priority task of the World Health Organization (WHO) is to preserve the health and harmonious development of each individual [1]
In order to make a comparative analysis of the socioeconomic determinants of health, we have identified three levels of indicators: the level of health expenditure, the structure of health expenditure and the expenditure on medicines
The ratio of health expenditure to the overall development of the economy may change over time because of the difference in the growth of health expenditure compared to the overall economic growth of the State
Summary
The priority task of the World Health Organization (WHO) is to preserve the health and harmonious development of each individual [1]. In 2005, WHO created The Commission on Social Determinants of Health (CSDH), which reviewed the evidence, conducted a social debate, and recommended policies to improve the health of the world’s socially disadvantaged. CSDH has articulated three main principles to guide national programming The extent and social causes of these injustices have become much better understood, as the report draws on global evidence and recommends policies, aimed at making progress in reducing health inequities and health disparities in all countries, including low-income countries, Taking action on the social determinants of health by influencing the course of life of the individual and in the broader social and economic spheres to achieve greater health equity and protect future generations [7, 8]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
